Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-632

I just can’t help but get the feeling that there is no sense of urgency in the way PAA management are operating. It is like they are on a “go slow” instruction.

As has been noted by others on this forum, other company’s appear to be pushing much harder for progress and their sp has responded accordingly.

Paa just moves at less than glacial speed. In fact, progress on any level, is so slow it makes the speed of a glacier look quick. Progress just does not seem to be happening.

It appears to me that Paa has dropped the ball since the Elanco deal failed to materialise. The fact that the second dog trial has taken so long to yield results is hard to explain. As is the small number of dog participants that it managed to attract for the trial, particularly after the Elanco feedback as to why it lost interest.

There just has to be some news soon. I am getting sick of watching the sp fall into the mire.